New study reveals shocking tattoo-lymphoma connection! Are your tattoos putting you at risk? Find out now!
Are tattoos a dangerous fashion statement? A recent Swedish study suggests a worrying link between tattoos and an increased risk of malignant lymphoma, a type of blood cancer that affects the lymphatic system. The study found that individuals with tattoos have a 21% higher risk of developing lymphoma, sparking concerns about the safety of tattoo ink and its potential carcinogenic effects. While more research is needed to fully understand this connection, the findings raise questions about the long-term health implications of getting inked.
In other news, Lymphoma Action is taking proactive steps to support those affected by lymphoma by hosting a Regional Lymphoma Day in Milton Keynes. This event aims to provide information and guidance to individuals dealing with lymphoma, offering a platform for education and support within the community. Additionally, the FDA approval of a self-test kit for HPV is empowering women to screen for cervical cancer in the comfort of their homes, highlighting the importance of early detection in combating this prevalent disease.
As the debate on tattoo safety continues, experts caution against drawing definitive conclusions. While some studies suggest a possible association between tattoos and lymphoma, others remain skeptical about the direct correlation. Despite the ongoing discussions, it is essential for individuals to prioritize their health and make informed decisions when it comes to body art and cancer risks.
It's crucial to stay informed about the potential health risks associated with tattoos and lymphoma. Remember, your health should always come first, whether it's attending support events like Regional Lymphoma Day or considering the implications of getting a tattoo. Stay vigilant and prioritize your well-being above all else!
On Friday 21 June, Lymphoma Action are hosting a Regional Lymphoma Day at the Leonardo Hotel to provide information and support to people affected by ...
Roche's self-collection kit allows women to screen for cervical cancer at home, offering an alternative to a visit to a healthcare provider and promoting ...
Tattoos may increase blood cancer risk by 21% · Tattoo ink contains known carcinogens, and can be transported around the body and end up in the lymph nodes.
A new Swedish study has found that tattooed individuals have a 21% increased risk for lymphoma, a type of blood cancer. Here's a deeper dive into a ...
Researchers "found no evidence to suggest that the risk increased" because of tattoos. Elsewhere, patients in England will be participating in a study to ...
(HealthDay News) โ Tattoo exposure is associated with an increased risk of several malignant lymphoma subtypes, according to a study published online in the ...
A Swedish study has found a potential link between tattoos and a type of cancer called malignant lymphoma, but it ultimately calls for more research on the ...
Recent study findings added to the body of research illuminating the various gaps affecting patients with DLBCL in limited-resource settings.1. Challenges of ...
Tattoos could increase your risk of getting certain cancers, according to a new study. Professor Robert Thomas looks into the findings.
Tattoos are made using a cocktail of inks that may contain compounds such as primary aromatic amines (PAA) and polycyclic aromatic hydrocarbons along with toxic ...
Researchers from Lund University in Sweden used population registers there to identify people who had been diagnosed with lymphoma, matching them with a control ...
โWe found that tattooed individuals had a 21% higher risk of overall malignant lymphoma compared with non-tattooed individuals and that the association was ...
A Swedish study has found a potential link between tattoos and a type of cancer called malignant lymphoma, but it ultimately calls for more research on the ...
A new brentuximab vedotin-containing regimen for classical Hodgkin lymphoma has been shown to be more tolerable and effective than the current standard.
The trial included 1500 patients with classical Hodgkin lymphoma (age range, 18-60) who were randomly assigned 1:1 to receive either 2 cycles of BrECADD or 2 ...
Brentuximab vedotin led to unprecedented progression-free survival for patients with classical Hodgkin lymphoma.
A brentuximab vedotin-containing regimen led to โunprecedentedโ progression-free survival improvements in patients with advanced classical Hodgkin lymphoma.
An Adcetris-based treatment regimen improved progression-free survival and was more tolerable for patients with classical Hodgkin lymphoma.
Peter Borchmann, MD, discusses the main takeaways from the GHSG HD21 study presented at the 2024 ASCO Annual Meeting.
The findings to be presented at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO).Dana-Farber Cancer Institute researchers.
Although advancements in the treatment of classical Hodgkin lymphoma have increased the 5-year relative survival rate of patients with the disease to nearly ...
A chimeric antigen receptor (CAR) T-cell therapy approved for patients with large B-cell lymphoma has produced positive results in a pilot study involving ...
Four-year Analysis Conducted by GHSG Reported ADCETRIS + ECADD Combination Improved Progression-Free Survival, Showing Superior Efficacy and Tolerable ...